Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis - ScienceDirect
Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis | Scientific Reports
Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan | BMC Pediatrics | Full Text
High infliximab trough concentrations are associated with sustained histologic remission in inflammatory bowel disease: a prospective cohort study | BMC Gastroenterology | Full Text
Summary of Primary and Secondary Efficacy Results from ACT 1 and ACT 2.* | Download Table
Optimizing management in IBD: Mucosal healing
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial - The Lancet Gastroenterology & Hepatology
Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis - ScienceDirect
JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis | NEJM
Rheumatologie und Gastroenterologie: TNF-alpha-Inhibition als erfolgreiches Wirkprinzip
Summary of Primary and Secondary Efficacy Results from ACT 1 and ACT 2.* | Download Table
Infliximab bei aktiver Colitis ulcerosa – Wirksamkeit als Induktions- und Erhaltungstherapie nachgewiesen
Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response - Gary R. Lichtenstein, 2013
Concentration vs. time curves of infliximab in (a) ulcerative colitis... | Download Scientific Diagram
Summary of study design among underlying trials. (A) Study flow... | Download Scientific Diagram
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis | NEJM
compendium.ch
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial - The Lancet Gastroenterology & Hepatology
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis | NEJM
Infliximab - Wikipedia
Clinical Information | REMICADE® (infliximab) HCP
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis | BMC Gastroenterology | Full Text
